Results 81 to 90 of about 82,991 (164)

Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma. [PDF]

open access: yesClin Cancer Res
Hanna GJ   +11 more
europepmc   +1 more source

Lithium-Charged Gold Nanoparticles: A New Powerful Tool for Lithium Delivery and Modulation of Glycogen Synthase Kinase 3 Activity. [PDF]

open access: yesAdv Mater
Buonerba A   +20 more
europepmc   +1 more source

Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2. [PDF]

open access: yesBlood Lymphat Cancer
Chen J   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy